Evolutionary characterization of lung cancer metastasis
Sonya Hessey(Royal London Hospital), Sanjay Jogai(University Hospital Southampton NHS Foundation Trust), Mark S. Hill(The Francis Crick Institute), Paulina Prymas(Cancer Research UK), Foteini Athanasopoulou(The Francis Crick Institute), Olivia Lucas(The Francis Crick Institute), Oriol Pich(The Francis Crick Institute), Sarah Benafif(Institute of Cancer Research), Abigail Bunkum(Cancer Research UK), Mary Falzon, Boyue Ding(University College London), Hayley Bridger(Cancer Research UK), Charlotte Grieco(Royal Marsden NHS Foundation Trust), Monica Sivakumar(Cancer Research UK), J. Le Quesne(NHS Greater Glasgow and Clyde), Gerald Langman(University Hospitals Birmingham NHS Foundation Trust), Caitlin F. Harrigan(University of Toronto), Kerstin Thol(Cancer Research UK), Selvaraju Veeriah(Cancer Research UK), C Richards(University of Leicester), Kristiana Grigoriadis(The Francis Crick Institute), Daniele Marinelli(London Cancer), Antonia Toncheva(Cancer Research UK), Miriam Mitchison(Royal London Hospital), A Green(Guy's and St Thomas' NHS Foundation Trust), Ariana Huebner(The Francis Crick Institute), Matthew Krebs(Christie's), Kerstin Haase(The Francis Crick Institute), Ula Mahadeva(St Thomas' Hospital), Ian Proctor, Carlos Martínez-Ruíz(The Francis Crick Institute), Fiona Blackhall(University of Manchester), Piotr Pawlik(Cancer Research UK), Babu Naidu(University of Birmingham), Anne Thomas(University of Leicester), Andrew J. Rowan(The Francis Crick Institute), Tanya Ahmad(University College London), Martin D Forster(Royal London Hospital), Sophia Ward(The Francis Crick Institute), Dean A Fennell(University of Leicester), Dionysis Papadatos-Pastos(Royal London Hospital), Pedro Oliveira(The Christie NHS Foundation Trust), Jamie Weaver(University of Manchester), Wing Kin Liu(Cancer Research UK), Siow Ming Lee(Royal London Hospital), Elaine Borg(Royal London Hospital), Yvonne Summers(University of Manchester), Corentin Richard(Centre Georges François Leclerc), Cristina Naceur-Lombardelli(Cancer Research UK), Takahiro Karasaki(The Francis Crick Institute)
Cited by 5
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k
First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer
|New England Journal of Medicine|2014|3.2k
The evolutionary history of 2,658 cancers
|Nature|2020|1.1k